nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—SLC15A2—choroid plexus—germ cell cancer	0.0293	0.49	CbGeAlD
Valganciclovir—SLC6A14—endocrine gland—germ cell cancer	0.00825	0.138	CbGeAlD
Valganciclovir—SLC15A2—retina—germ cell cancer	0.00224	0.0374	CbGeAlD
Valganciclovir—SLC15A1—endocrine gland—germ cell cancer	0.00208	0.0348	CbGeAlD
Valganciclovir—SLC15A2—telencephalon—germ cell cancer	0.00206	0.0344	CbGeAlD
Valganciclovir—Mediastinal disorder—Cisplatin—germ cell cancer	0.00186	0.00198	CcSEcCtD
Valganciclovir—Hypotension—Bleomycin—germ cell cancer	0.00186	0.00197	CcSEcCtD
Valganciclovir—Oedema—Dactinomycin—germ cell cancer	0.00185	0.00197	CcSEcCtD
Valganciclovir—Urethral disorder—Etoposide—germ cell cancer	0.00185	0.00197	CcSEcCtD
Valganciclovir—Infection—Dactinomycin—germ cell cancer	0.00184	0.00196	CcSEcCtD
Valganciclovir—Arrhythmia—Cisplatin—germ cell cancer	0.00184	0.00196	CcSEcCtD
Valganciclovir—Alopecia—Cisplatin—germ cell cancer	0.00182	0.00194	CcSEcCtD
Valganciclovir—Cough—Ifosfamide—germ cell cancer	0.00182	0.00193	CcSEcCtD
Valganciclovir—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00181	0.00193	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00181	0.00193	CcSEcCtD
Valganciclovir—Convulsion—Ifosfamide—germ cell cancer	0.0018	0.00192	CcSEcCtD
Valganciclovir—Hypertension—Ifosfamide—germ cell cancer	0.0018	0.00191	CcSEcCtD
Valganciclovir—Malnutrition—Cisplatin—germ cell cancer	0.00179	0.00191	CcSEcCtD
Valganciclovir—Paraesthesia—Bleomycin—germ cell cancer	0.00178	0.0019	CcSEcCtD
Valganciclovir—Dyspnoea—Bleomycin—germ cell cancer	0.00177	0.00188	CcSEcCtD
Valganciclovir—Arthralgia—Ifosfamide—germ cell cancer	0.00177	0.00188	CcSEcCtD
Valganciclovir—Flatulence—Cisplatin—germ cell cancer	0.00177	0.00188	CcSEcCtD
Valganciclovir—Anorexia—Dactinomycin—germ cell cancer	0.00177	0.00188	CcSEcCtD
Valganciclovir—Eye disorder—Etoposide—germ cell cancer	0.00176	0.00188	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00176	0.00187	CcSEcCtD
Valganciclovir—Cardiac disorder—Etoposide—germ cell cancer	0.00175	0.00186	CcSEcCtD
Valganciclovir—Discomfort—Ifosfamide—germ cell cancer	0.00175	0.00186	CcSEcCtD
Valganciclovir—Hypersensitivity—Vinblastine—germ cell cancer	0.00173	0.00184	CcSEcCtD
Valganciclovir—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.00173	0.00184	CcSEcCtD
Valganciclovir—Decreased appetite—Bleomycin—germ cell cancer	0.00173	0.00184	CcSEcCtD
Valganciclovir—Muscle spasms—Cisplatin—germ cell cancer	0.00172	0.00183	CcSEcCtD
Valganciclovir—Angiopathy—Etoposide—germ cell cancer	0.00171	0.00182	CcSEcCtD
Valganciclovir—Confusional state—Ifosfamide—germ cell cancer	0.00171	0.00182	CcSEcCtD
Valganciclovir—Immune system disorder—Etoposide—germ cell cancer	0.0017	0.00181	CcSEcCtD
Valganciclovir—Mediastinal disorder—Etoposide—germ cell cancer	0.0017	0.00181	CcSEcCtD
Valganciclovir—Pain—Bleomycin—germ cell cancer	0.0017	0.00181	CcSEcCtD
Valganciclovir—Oedema—Ifosfamide—germ cell cancer	0.0017	0.00181	CcSEcCtD
Valganciclovir—Anaphylactic shock—Ifosfamide—germ cell cancer	0.0017	0.00181	CcSEcCtD
Valganciclovir—Chills—Etoposide—germ cell cancer	0.00169	0.0018	CcSEcCtD
Valganciclovir—Vision blurred—Cisplatin—germ cell cancer	0.00169	0.0018	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00169	0.0018	CcSEcCtD
Valganciclovir—Asthenia—Vinblastine—germ cell cancer	0.00169	0.0018	CcSEcCtD
Valganciclovir—Infection—Ifosfamide—germ cell cancer	0.00169	0.00179	CcSEcCtD
Valganciclovir—Tremor—Cisplatin—germ cell cancer	0.00168	0.00179	CcSEcCtD
Valganciclovir—SLC15A2—pituitary gland—germ cell cancer	0.00168	0.028	CbGeAlD
Valganciclovir—Alopecia—Etoposide—germ cell cancer	0.00167	0.00177	CcSEcCtD
Valganciclovir—Nervous system disorder—Ifosfamide—germ cell cancer	0.00167	0.00177	CcSEcCtD
Valganciclovir—Ill-defined disorder—Cisplatin—germ cell cancer	0.00166	0.00177	CcSEcCtD
Valganciclovir—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00166	0.00177	CcSEcCtD
Valganciclovir—Anaemia—Cisplatin—germ cell cancer	0.00166	0.00176	CcSEcCtD
Valganciclovir—Skin disorder—Ifosfamide—germ cell cancer	0.00165	0.00175	CcSEcCtD
Valganciclovir—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00164	0.00175	CcSEcCtD
Valganciclovir—Feeling abnormal—Bleomycin—germ cell cancer	0.00164	0.00174	CcSEcCtD
Valganciclovir—SLC15A2—medulla oblongata—germ cell cancer	0.00162	0.0271	CbGeAlD
Valganciclovir—Anorexia—Ifosfamide—germ cell cancer	0.00162	0.00172	CcSEcCtD
Valganciclovir—Malaise—Cisplatin—germ cell cancer	0.00162	0.00172	CcSEcCtD
Valganciclovir—Decreased appetite—Dactinomycin—germ cell cancer	0.00161	0.00171	CcSEcCtD
Valganciclovir—Diarrhoea—Vinblastine—germ cell cancer	0.00161	0.00171	CcSEcCtD
Valganciclovir—Dysgeusia—Etoposide—germ cell cancer	0.00161	0.00171	CcSEcCtD
Valganciclovir—Leukopenia—Cisplatin—germ cell cancer	0.00161	0.00171	CcSEcCtD
Valganciclovir—Fatigue—Dactinomycin—germ cell cancer	0.0016	0.0017	CcSEcCtD
Valganciclovir—Back pain—Etoposide—germ cell cancer	0.00159	0.00169	CcSEcCtD
Valganciclovir—Hypotension—Ifosfamide—germ cell cancer	0.00159	0.00169	CcSEcCtD
Valganciclovir—Pain—Dactinomycin—germ cell cancer	0.00158	0.00169	CcSEcCtD
Valganciclovir—Muscle spasms—Etoposide—germ cell cancer	0.00158	0.00168	CcSEcCtD
Valganciclovir—Urticaria—Bleomycin—germ cell cancer	0.00158	0.00168	CcSEcCtD
Valganciclovir—Body temperature increased—Bleomycin—germ cell cancer	0.00157	0.00167	CcSEcCtD
Valganciclovir—Dizziness—Vinblastine—germ cell cancer	0.00156	0.00165	CcSEcCtD
Valganciclovir—Convulsion—Cisplatin—germ cell cancer	0.00155	0.00165	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00155	0.00165	CcSEcCtD
Valganciclovir—Ataxia—Methotrexate—germ cell cancer	0.00154	0.00163	CcSEcCtD
Valganciclovir—Feeling abnormal—Dactinomycin—germ cell cancer	0.00153	0.00162	CcSEcCtD
Valganciclovir—Paraesthesia—Ifosfamide—germ cell cancer	0.00152	0.00162	CcSEcCtD
Valganciclovir—Ill-defined disorder—Etoposide—germ cell cancer	0.00152	0.00162	CcSEcCtD
Valganciclovir—Anxiety—Cisplatin—germ cell cancer	0.00152	0.00162	CcSEcCtD
Valganciclovir—Anaemia—Etoposide—germ cell cancer	0.00152	0.00162	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00152	0.00161	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00152	0.00161	CcSEcCtD
Valganciclovir—Dyspnoea—Ifosfamide—germ cell cancer	0.00151	0.00161	CcSEcCtD
Valganciclovir—Somnolence—Ifosfamide—germ cell cancer	0.00151	0.00161	CcSEcCtD
Valganciclovir—Discomfort—Cisplatin—germ cell cancer	0.00151	0.0016	CcSEcCtD
Valganciclovir—SLC15A2—adrenal gland—germ cell cancer	0.0015	0.0251	CbGeAlD
Valganciclovir—Vomiting—Vinblastine—germ cell cancer	0.0015	0.00159	CcSEcCtD
Valganciclovir—Malaise—Etoposide—germ cell cancer	0.00148	0.00158	CcSEcCtD
Valganciclovir—SLC15A2—midbrain—germ cell cancer	0.00148	0.0247	CbGeAlD
Valganciclovir—Vertigo—Etoposide—germ cell cancer	0.00148	0.00157	CcSEcCtD
Valganciclovir—Decreased appetite—Ifosfamide—germ cell cancer	0.00148	0.00157	CcSEcCtD
Valganciclovir—Headache—Vinblastine—germ cell cancer	0.00147	0.00157	CcSEcCtD
Valganciclovir—Leukopenia—Etoposide—germ cell cancer	0.00147	0.00156	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00147	0.00156	CcSEcCtD
Valganciclovir—Body temperature increased—Dactinomycin—germ cell cancer	0.00146	0.00156	CcSEcCtD
Valganciclovir—Abdominal pain—Dactinomycin—germ cell cancer	0.00146	0.00156	CcSEcCtD
Valganciclovir—Fatigue—Ifosfamide—germ cell cancer	0.00146	0.00156	CcSEcCtD
Valganciclovir—Oedema—Cisplatin—germ cell cancer	0.00146	0.00156	CcSEcCtD
Valganciclovir—Anaphylactic shock—Cisplatin—germ cell cancer	0.00146	0.00156	CcSEcCtD
Valganciclovir—Hypersensitivity—Bleomycin—germ cell cancer	0.00146	0.00156	CcSEcCtD
Valganciclovir—Infection—Cisplatin—germ cell cancer	0.00145	0.00155	CcSEcCtD
Valganciclovir—Pain—Ifosfamide—germ cell cancer	0.00145	0.00154	CcSEcCtD
Valganciclovir—Constipation—Ifosfamide—germ cell cancer	0.00145	0.00154	CcSEcCtD
Valganciclovir—SLC15A2—spinal cord—germ cell cancer	0.00144	0.0241	CbGeAlD
Valganciclovir—Nervous system disorder—Cisplatin—germ cell cancer	0.00144	0.00153	CcSEcCtD
Valganciclovir—Cough—Etoposide—germ cell cancer	0.00143	0.00153	CcSEcCtD
Valganciclovir—Thrombocytopenia—Cisplatin—germ cell cancer	0.00143	0.00152	CcSEcCtD
Valganciclovir—Tachycardia—Cisplatin—germ cell cancer	0.00143	0.00152	CcSEcCtD
Valganciclovir—Asthenia—Bleomycin—germ cell cancer	0.00143	0.00152	CcSEcCtD
Valganciclovir—Convulsion—Etoposide—germ cell cancer	0.00142	0.00151	CcSEcCtD
Valganciclovir—Skin disorder—Cisplatin—germ cell cancer	0.00142	0.00151	CcSEcCtD
Valganciclovir—Hypertension—Etoposide—germ cell cancer	0.00142	0.00151	CcSEcCtD
Valganciclovir—Hyperhidrosis—Cisplatin—germ cell cancer	0.00142	0.00151	CcSEcCtD
Valganciclovir—Pruritus—Bleomycin—germ cell cancer	0.00141	0.0015	CcSEcCtD
Valganciclovir—Feeling abnormal—Ifosfamide—germ cell cancer	0.0014	0.00149	CcSEcCtD
Valganciclovir—Eosinophilia—Methotrexate—germ cell cancer	0.0014	0.00149	CcSEcCtD
Valganciclovir—SLC15A2—female gonad—germ cell cancer	0.0014	0.0234	CbGeAlD
Valganciclovir—Nausea—Vinblastine—germ cell cancer	0.0014	0.00149	CcSEcCtD
Valganciclovir—Anorexia—Cisplatin—germ cell cancer	0.0014	0.00148	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00139	0.00148	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00139	0.00148	CcSEcCtD
Valganciclovir—Pancreatitis—Methotrexate—germ cell cancer	0.00138	0.00147	CcSEcCtD
Valganciclovir—Discomfort—Etoposide—germ cell cancer	0.00138	0.00147	CcSEcCtD
Valganciclovir—Hypotension—Cisplatin—germ cell cancer	0.00137	0.00145	CcSEcCtD
Valganciclovir—Hypersensitivity—Dactinomycin—germ cell cancer	0.00137	0.00145	CcSEcCtD
Valganciclovir—Confusional state—Etoposide—germ cell cancer	0.00135	0.00144	CcSEcCtD
Valganciclovir—Urticaria—Ifosfamide—germ cell cancer	0.00135	0.00143	CcSEcCtD
Valganciclovir—Abdominal pain—Ifosfamide—germ cell cancer	0.00134	0.00143	CcSEcCtD
Valganciclovir—Body temperature increased—Ifosfamide—germ cell cancer	0.00134	0.00143	CcSEcCtD
Valganciclovir—Pancytopenia—Methotrexate—germ cell cancer	0.00134	0.00143	CcSEcCtD
Valganciclovir—Anaphylactic shock—Etoposide—germ cell cancer	0.00134	0.00143	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00133	0.00142	CcSEcCtD
Valganciclovir—Infection—Etoposide—germ cell cancer	0.00133	0.00142	CcSEcCtD
Valganciclovir—Asthenia—Dactinomycin—germ cell cancer	0.00133	0.00141	CcSEcCtD
Valganciclovir—Dysuria—Methotrexate—germ cell cancer	0.00132	0.0014	CcSEcCtD
Valganciclovir—Neutropenia—Methotrexate—germ cell cancer	0.00132	0.0014	CcSEcCtD
Valganciclovir—Paraesthesia—Cisplatin—germ cell cancer	0.00131	0.0014	CcSEcCtD
Valganciclovir—Thrombocytopenia—Etoposide—germ cell cancer	0.00131	0.0014	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.00131	0.0014	CcSEcCtD
Valganciclovir—Tachycardia—Etoposide—germ cell cancer	0.00131	0.00139	CcSEcCtD
Valganciclovir—Dyspnoea—Cisplatin—germ cell cancer	0.00131	0.00139	CcSEcCtD
Valganciclovir—Skin disorder—Etoposide—germ cell cancer	0.0013	0.00139	CcSEcCtD
Valganciclovir—Erectile dysfunction—Methotrexate—germ cell cancer	0.0013	0.00138	CcSEcCtD
Valganciclovir—SLC15A2—endocrine gland—germ cell cancer	0.0013	0.0217	CbGeAlD
Valganciclovir—Hyperhidrosis—Etoposide—germ cell cancer	0.0013	0.00138	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Methotrexate—germ cell cancer	0.00129	0.00137	CcSEcCtD
Valganciclovir—SLC15A2—head—germ cell cancer	0.00128	0.0215	CbGeAlD
Valganciclovir—Anorexia—Etoposide—germ cell cancer	0.00128	0.00136	CcSEcCtD
Valganciclovir—Decreased appetite—Cisplatin—germ cell cancer	0.00127	0.00135	CcSEcCtD
Valganciclovir—Diarrhoea—Dactinomycin—germ cell cancer	0.00127	0.00135	CcSEcCtD
Valganciclovir—Pneumonia—Methotrexate—germ cell cancer	0.00127	0.00135	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00126	0.00134	CcSEcCtD
Valganciclovir—Vomiting—Bleomycin—germ cell cancer	0.00126	0.00134	CcSEcCtD
Valganciclovir—Infestation NOS—Methotrexate—germ cell cancer	0.00126	0.00134	CcSEcCtD
Valganciclovir—Infestation—Methotrexate—germ cell cancer	0.00126	0.00134	CcSEcCtD
Valganciclovir—Depression—Methotrexate—germ cell cancer	0.00126	0.00134	CcSEcCtD
Valganciclovir—Hypotension—Etoposide—germ cell cancer	0.00125	0.00133	CcSEcCtD
Valganciclovir—Pain—Cisplatin—germ cell cancer	0.00125	0.00133	CcSEcCtD
Valganciclovir—Dermatitis—Bleomycin—germ cell cancer	0.00125	0.00133	CcSEcCtD
Valganciclovir—Hypersensitivity—Ifosfamide—germ cell cancer	0.00125	0.00133	CcSEcCtD
Valganciclovir—SLC15A2—testis—germ cell cancer	0.00124	0.0207	CbGeAlD
Valganciclovir—Renal failure—Methotrexate—germ cell cancer	0.00124	0.00132	CcSEcCtD
Valganciclovir—Stomatitis—Methotrexate—germ cell cancer	0.00123	0.00131	CcSEcCtD
Valganciclovir—Asthenia—Ifosfamide—germ cell cancer	0.00122	0.0013	CcSEcCtD
Valganciclovir—Feeling abnormal—Cisplatin—germ cell cancer	0.00121	0.00128	CcSEcCtD
Valganciclovir—Paraesthesia—Etoposide—germ cell cancer	0.0012	0.00128	CcSEcCtD
Valganciclovir—Pruritus—Ifosfamide—germ cell cancer	0.0012	0.00128	CcSEcCtD
Valganciclovir—Haematuria—Methotrexate—germ cell cancer	0.0012	0.00128	CcSEcCtD
Valganciclovir—Dyspnoea—Etoposide—germ cell cancer	0.0012	0.00127	CcSEcCtD
Valganciclovir—Somnolence—Etoposide—germ cell cancer	0.00119	0.00127	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00119	0.00127	CcSEcCtD
Valganciclovir—Nausea—Bleomycin—germ cell cancer	0.00118	0.00126	CcSEcCtD
Valganciclovir—Vomiting—Dactinomycin—germ cell cancer	0.00118	0.00125	CcSEcCtD
Valganciclovir—Decreased appetite—Etoposide—germ cell cancer	0.00117	0.00124	CcSEcCtD
Valganciclovir—Diarrhoea—Ifosfamide—germ cell cancer	0.00116	0.00124	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00116	0.00123	CcSEcCtD
Valganciclovir—Body temperature increased—Cisplatin—germ cell cancer	0.00116	0.00123	CcSEcCtD
Valganciclovir—Fatigue—Etoposide—germ cell cancer	0.00116	0.00123	CcSEcCtD
Valganciclovir—Pain—Etoposide—germ cell cancer	0.00115	0.00122	CcSEcCtD
Valganciclovir—Constipation—Etoposide—germ cell cancer	0.00115	0.00122	CcSEcCtD
Valganciclovir—SLC15A2—cerebellum—germ cell cancer	0.00115	0.0191	CbGeAlD
Valganciclovir—Haemoglobin—Methotrexate—germ cell cancer	0.00114	0.00121	CcSEcCtD
Valganciclovir—Haemorrhage—Methotrexate—germ cell cancer	0.00113	0.0012	CcSEcCtD
Valganciclovir—Hepatitis—Methotrexate—germ cell cancer	0.00113	0.0012	CcSEcCtD
Valganciclovir—Dizziness—Ifosfamide—germ cell cancer	0.00112	0.00119	CcSEcCtD
Valganciclovir—Pharyngitis—Methotrexate—germ cell cancer	0.00112	0.00119	CcSEcCtD
Valganciclovir—Urinary tract disorder—Methotrexate—germ cell cancer	0.00112	0.00119	CcSEcCtD
Valganciclovir—Urethral disorder—Methotrexate—germ cell cancer	0.00111	0.00118	CcSEcCtD
Valganciclovir—Feeling abnormal—Etoposide—germ cell cancer	0.00111	0.00118	CcSEcCtD
Valganciclovir—Nausea—Dactinomycin—germ cell cancer	0.0011	0.00117	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Etoposide—germ cell cancer	0.0011	0.00117	CcSEcCtD
Valganciclovir—Visual impairment—Methotrexate—germ cell cancer	0.00109	0.00116	CcSEcCtD
Valganciclovir—Vomiting—Ifosfamide—germ cell cancer	0.00108	0.00115	CcSEcCtD
Valganciclovir—Hypersensitivity—Cisplatin—germ cell cancer	0.00108	0.00115	CcSEcCtD
Valganciclovir—Dermatitis—Ifosfamide—germ cell cancer	0.00107	0.00114	CcSEcCtD
Valganciclovir—Urticaria—Etoposide—germ cell cancer	0.00107	0.00113	CcSEcCtD
Valganciclovir—Body temperature increased—Etoposide—germ cell cancer	0.00106	0.00113	CcSEcCtD
Valganciclovir—Abdominal pain—Etoposide—germ cell cancer	0.00106	0.00113	CcSEcCtD
Valganciclovir—Eye disorder—Methotrexate—germ cell cancer	0.00106	0.00112	CcSEcCtD
Valganciclovir—Tinnitus—Methotrexate—germ cell cancer	0.00105	0.00112	CcSEcCtD
Valganciclovir—Asthenia—Cisplatin—germ cell cancer	0.00105	0.00112	CcSEcCtD
Valganciclovir—Cardiac disorder—Methotrexate—germ cell cancer	0.00105	0.00112	CcSEcCtD
Valganciclovir—Angiopathy—Methotrexate—germ cell cancer	0.00103	0.00109	CcSEcCtD
Valganciclovir—Immune system disorder—Methotrexate—germ cell cancer	0.00102	0.00109	CcSEcCtD
Valganciclovir—Mediastinal disorder—Methotrexate—germ cell cancer	0.00102	0.00108	CcSEcCtD
Valganciclovir—Chills—Methotrexate—germ cell cancer	0.00101	0.00108	CcSEcCtD
Valganciclovir—Nausea—Ifosfamide—germ cell cancer	0.00101	0.00107	CcSEcCtD
Valganciclovir—Diarrhoea—Cisplatin—germ cell cancer	0.001	0.00107	CcSEcCtD
Valganciclovir—Alopecia—Methotrexate—germ cell cancer	0.000999	0.00106	CcSEcCtD
Valganciclovir—Mental disorder—Methotrexate—germ cell cancer	0.000991	0.00105	CcSEcCtD
Valganciclovir—Hypersensitivity—Etoposide—germ cell cancer	0.000988	0.00105	CcSEcCtD
Valganciclovir—Malnutrition—Methotrexate—germ cell cancer	0.000984	0.00105	CcSEcCtD
Valganciclovir—Dysgeusia—Methotrexate—germ cell cancer	0.000964	0.00103	CcSEcCtD
Valganciclovir—Asthenia—Etoposide—germ cell cancer	0.000962	0.00102	CcSEcCtD
Valganciclovir—Back pain—Methotrexate—germ cell cancer	0.000952	0.00101	CcSEcCtD
Valganciclovir—Pruritus—Etoposide—germ cell cancer	0.000949	0.00101	CcSEcCtD
Valganciclovir—Vomiting—Cisplatin—germ cell cancer	0.000931	0.00099	CcSEcCtD
Valganciclovir—SLC15A2—brain—germ cell cancer	0.00093	0.0155	CbGeAlD
Valganciclovir—Vision blurred—Methotrexate—germ cell cancer	0.000928	0.000987	CcSEcCtD
Valganciclovir—Dermatitis—Cisplatin—germ cell cancer	0.000922	0.000981	CcSEcCtD
Valganciclovir—Diarrhoea—Etoposide—germ cell cancer	0.000918	0.000976	CcSEcCtD
Valganciclovir—Ill-defined disorder—Methotrexate—germ cell cancer	0.000913	0.000971	CcSEcCtD
Valganciclovir—Anaemia—Methotrexate—germ cell cancer	0.00091	0.000968	CcSEcCtD
Valganciclovir—SLC15A2—lymph node—germ cell cancer	0.000899	0.015	CbGeAlD
Valganciclovir—Malaise—Methotrexate—germ cell cancer	0.000888	0.000944	CcSEcCtD
Valganciclovir—Dizziness—Etoposide—germ cell cancer	0.000887	0.000943	CcSEcCtD
Valganciclovir—Vertigo—Methotrexate—germ cell cancer	0.000884	0.000941	CcSEcCtD
Valganciclovir—Leukopenia—Methotrexate—germ cell cancer	0.000881	0.000937	CcSEcCtD
Valganciclovir—Nausea—Cisplatin—germ cell cancer	0.00087	0.000925	CcSEcCtD
Valganciclovir—Cough—Methotrexate—germ cell cancer	0.000859	0.000914	CcSEcCtD
Valganciclovir—Convulsion—Methotrexate—germ cell cancer	0.000853	0.000907	CcSEcCtD
Valganciclovir—Vomiting—Etoposide—germ cell cancer	0.000853	0.000907	CcSEcCtD
Valganciclovir—Dermatitis—Etoposide—germ cell cancer	0.000845	0.000899	CcSEcCtD
Valganciclovir—Headache—Etoposide—germ cell cancer	0.00084	0.000894	CcSEcCtD
Valganciclovir—Arthralgia—Methotrexate—germ cell cancer	0.000838	0.000891	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000832	0.000885	CcSEcCtD
Valganciclovir—Discomfort—Methotrexate—germ cell cancer	0.000828	0.000881	CcSEcCtD
Valganciclovir—Confusional state—Methotrexate—germ cell cancer	0.00081	0.000862	CcSEcCtD
Valganciclovir—Anaphylactic shock—Methotrexate—germ cell cancer	0.000803	0.000854	CcSEcCtD
Valganciclovir—Infection—Methotrexate—germ cell cancer	0.000798	0.000849	CcSEcCtD
Valganciclovir—Nausea—Etoposide—germ cell cancer	0.000797	0.000847	CcSEcCtD
Valganciclovir—Nervous system disorder—Methotrexate—germ cell cancer	0.000788	0.000838	CcSEcCtD
Valganciclovir—Thrombocytopenia—Methotrexate—germ cell cancer	0.000786	0.000837	CcSEcCtD
Valganciclovir—Skin disorder—Methotrexate—germ cell cancer	0.00078	0.00083	CcSEcCtD
Valganciclovir—Hyperhidrosis—Methotrexate—germ cell cancer	0.000777	0.000826	CcSEcCtD
Valganciclovir—Anorexia—Methotrexate—germ cell cancer	0.000766	0.000814	CcSEcCtD
Valganciclovir—Hypotension—Methotrexate—germ cell cancer	0.000751	0.000798	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000732	0.000778	CcSEcCtD
Valganciclovir—Insomnia—Methotrexate—germ cell cancer	0.000727	0.000773	CcSEcCtD
Valganciclovir—Paraesthesia—Methotrexate—germ cell cancer	0.000721	0.000767	CcSEcCtD
Valganciclovir—Dyspnoea—Methotrexate—germ cell cancer	0.000716	0.000762	CcSEcCtD
Valganciclovir—Somnolence—Methotrexate—germ cell cancer	0.000714	0.00076	CcSEcCtD
Valganciclovir—Dyspepsia—Methotrexate—germ cell cancer	0.000707	0.000752	CcSEcCtD
Valganciclovir—Decreased appetite—Methotrexate—germ cell cancer	0.000698	0.000743	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000694	0.000738	CcSEcCtD
Valganciclovir—Fatigue—Methotrexate—germ cell cancer	0.000693	0.000737	CcSEcCtD
Valganciclovir—Pain—Methotrexate—germ cell cancer	0.000687	0.000731	CcSEcCtD
Valganciclovir—Feeling abnormal—Methotrexate—germ cell cancer	0.000662	0.000704	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000657	0.000699	CcSEcCtD
Valganciclovir—Urticaria—Methotrexate—germ cell cancer	0.000638	0.000679	CcSEcCtD
Valganciclovir—Body temperature increased—Methotrexate—germ cell cancer	0.000635	0.000675	CcSEcCtD
Valganciclovir—Abdominal pain—Methotrexate—germ cell cancer	0.000635	0.000675	CcSEcCtD
Valganciclovir—Hypersensitivity—Methotrexate—germ cell cancer	0.000592	0.00063	CcSEcCtD
Valganciclovir—Asthenia—Methotrexate—germ cell cancer	0.000576	0.000613	CcSEcCtD
Valganciclovir—Pruritus—Methotrexate—germ cell cancer	0.000568	0.000604	CcSEcCtD
Valganciclovir—Diarrhoea—Methotrexate—germ cell cancer	0.00055	0.000585	CcSEcCtD
Valganciclovir—Dizziness—Methotrexate—germ cell cancer	0.000531	0.000565	CcSEcCtD
Valganciclovir—Vomiting—Methotrexate—germ cell cancer	0.000511	0.000543	CcSEcCtD
Valganciclovir—Dermatitis—Methotrexate—germ cell cancer	0.000506	0.000538	CcSEcCtD
Valganciclovir—Headache—Methotrexate—germ cell cancer	0.000503	0.000535	CcSEcCtD
Valganciclovir—Nausea—Methotrexate—germ cell cancer	0.000477	0.000508	CcSEcCtD
